Duolip

Known as: Merckle brand of etofyllinclofibrate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-1995
051019801995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
BACKGROUND Duolip forte (ethophyllinclofibrate) is a lipid lowering drug, the effect of which was not yet adequately verified in… (More)
Is this relevant?
1994
1994
BACKGROUND Insulin resistance and hypertriacylglycerolaemia are part of the X syndrome and are supposed to be interrelated. The… (More)
Is this relevant?
1993
1993
Duolip forte (ethophylline clofibrate, tablets à 500 mg) produced by Merckle Austria was administered to 20 patients with… (More)
Is this relevant?
1986
1986
1-(7-Theophyllinyl)-2-ethyl-[2-(p-chlorophenoxy)-isobutyrate] (etofylline clofibrate, theofibrate, Duolip) was shown to possess… (More)
Is this relevant?
1983
1983
During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In… (More)
Is this relevant?
1980
1980
The biopharmaceutic criteria of Duolip and its active principle, 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2… (More)
Is this relevant?
Review
1980
Review
1980
In a review study including altogether 5 clinical trials with a total of 221 hyperlipidaemic patients the influence of 1… (More)
Is this relevant?
1980
1980
The hypolipaemic potential of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML… (More)
Is this relevant?
1980
1980
Efficacy and tolerance of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, Duolip… (More)
Is this relevant?
1980
1980
Upon investigations on metabolism and pharmacokinetics of 1-(theophyllin-7-yl)-ethyl-2-[2-(chlorophenoxy)-2-methylpropionate… (More)
Is this relevant?